PULSE GEN MODEL 100
Report
- Report Number
- 1644487-2009-01145
- Event Type
- Injury
- Date Received
- June 5, 2009
- Date of Event
- September 26, 2000
- Report Date
- May 28, 2009
- Manufacturer
- CYBERONICS, INC.
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER
Narratives
ARTICLE CITATION: KOUTROUMANIDIS, MICHAEL, MICHAEL J. HENNESSY, COLIN D. BINNIE, AND CHARLES E. POLKEY. "AGGRAVATION OF PARTIAL EPILEPSY AND EMERGENCE OF NEW SEIZURE TYPE DURING TREATMENT WITH VNS." NEUROLOGY 55 (2000): 892-93.
IT WAS REPORTED IN A SCIENTIFIC ARTICLE THAT A VNS PATIENT, WHO HAD INITIALLY RESPONDED TO VNS THERAPY, BEGAN TO EXPERIENCE AN "ABRUPT WORSENING OF HER EPILEPSY" AFTER INCREASING HER THERAPY OUTPUT CURRENT BY 0.25MA (2.25MA TO 2.50MA). THE AUTHOR INDICATED THAT THIS WORSENED SEIZURE ACTIVITY CONSISTED OF AN INCREASE IN SEIZURE FREQUENCY, ABOVE PRE-VNS BASELINE LEVELS, AS WELL AS THE DEVELOPMENT OF A NEW SEIZURE TYPE. THE ARTICLE STATES THAT THE PATIENT HAD "NO HISTORY OF RECENT AED CHANGES OR DOSE OMISSION, PROTRACTED SLEEP DEPRIVATION, STRESSFUL EVENTS, TRAUMA, OR INTERVENING INFECTION COULD BE ELICITED AND BOTH THE GENERATOR AND THE LEAD WERE FUNCTIONING NORMALLY". THE AUTHOR STATES THAT ONCE THE PATIENT'S NCP DEVICE WAS PROGRAMMED OFF, "2 DAYS LATER THE NEW SEIZURE TYPE CEASED AND THE PATIENT'S HABITUAL SEIZURES SETTLED DOWN TO PRE-IMPLANTATION BASELINE." IN LIGHT OF THESE EVENTS, THE PT'S DEVICE WAS REPORTEDLY PROGRAMMED BACK ON A MONTH LATER DUE TO THE INITIAL EFFICACY SHE HAD RECEIVED FROM VNS THERAPY. THE PT'S OUTPUT CURRENT WAS GRADUALLY INCREASED UP TO 1.75MA AND AFTER SIX MONTHS OF FOLLOW UP, THE PATIENT REPORTEDLY REGAINED THE EFFICACY THAT SHE HAD INITIALLY OBTAINED WITH NO RELAPSE OF THE NEW SEIZURE TYPE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PULSE GEN MODEL 100 | LYJ | CYBERONICS, INC. | 100 C |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 20 YR | Required Intervention |